Azemat Jamshidi‐Parsian

Federal Grant PI

Researcher

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

17 h-index 56 pubs 1,511 cited

Research Areas

Links

ORCID Research Group

OverviewAI-generated summary

Azemat Jamshidi‐Parsian's research focuses on cancer biology and therapeutic strategies, with a particular emphasis on the role of extracellular vesicles and novel drug delivery systems. Dr. Jamshidi‐Parsian has investigated the mechanisms by which pancreatic cancer extracellular vesicles stimulate Schwann cell activation, contributing to perineural invasion. Further work explores exosomal microRNA and protein profiles in hepatocellular carcinoma cells and the proteomic basis of modulation of postischemic fibrosis by mesenchymal stem cell exosomes.

In the realm of cancer treatment, Dr. Jamshidi‐Parsian's work includes the development of liposome formulations for tumor-targeted drug delivery in conjunction with radiation therapy. The group also studies the effects of specific compounds, such as CB-839, on inducing reversible dormancy in lung tumor cells. A federal grant from the NIH/National Cancer Institute, totaling $348,182, supports research on the improvement of cellular immunotherapy during dysbiosis. Dr. Jamshidi‐Parsian leads a research group and has a publication record that includes work on nanopore sequencing for glioma characterization and the photothermal response of artificial extracellular matrices for neural stem cell differentiation.

Dr. Jamshidi‐Parsian's scholarship metrics include an h-index of 17, with 56 total publications and 1,492 total citations. Key collaborators include Robert J. Griffin and Samir V. Jenkins from the University of Arkansas for Medical Sciences, and Ruud P.M. Dings from the University of Arkansas at Fayetteville.

Metrics

h-index: 17
Publications: 56
Citations: 1,511

Selected Publications

Gene Expression Profile of Gm20594 and Hapln1 in Mouse Cardiac Muscle Exposed to Microgravity and Space-like Chronic Low-Dose Radiation (2025)

DOI OpenAlex
Musculoskeletal miRNA profiling after exposure to simulated space stressors in mice (2025)

DOI OpenAlex
Pancreatic cancer extracellular vesicles stimulate Schwann cell activation and perineural invasion in vitro via IL-8/CCL2 (2025)

4 citations DOI OpenAlex
Abstract B026: Pancreatic tumor extracellular vesicles induce perineural invasion in vitro via IL- 8/CCL2 (2024)

1 citation DOI OpenAlex
Pancreatic Cancer Extracellular Vesicles Stimulate Schwann Cell Activation and Perineural Invasion in Vitro Via Il-8/Ccl2 (2024)

DOI OpenAlex
Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A (2024)

DOI OpenAlex
Morphological Effects and In Vitro Biological Mechanisms of Radiation-Induced Cell Killing by Gold Nanomaterials (2023)

2 citations DOI OpenAlex
Exosomal MicroRNA and Protein Profiles of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells (2023)

10 citations DOI OpenAlex
Exploiting nanopore sequencing for characterization and grading of <i>IDH</i>‐mutant gliomas (2023)

11 citations DOI OpenAlex
Pancreatic Tumor-Derived Extracellular Vesicles Stimulate Schwann Cell Phenotype Indicative of Perineural Invasion via IL-8 Signaling (2023)

4 citations DOI OpenAlex
Proteomic analysis of transcription factors involved in the alteration of ischemic mouse heart as modulated by MSC exosomes (2023)

1 citation DOI OpenAlex
Proteomic Analysis of Transcription Factors Involved in the Alteration of Ischemic Mouse Heart as Modulated by MSC Exosomes (2023)

1 citation DOI OpenAlex
Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy (2022)

8 citations DOI OpenAlex
Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy (2022)

4 citations DOI OpenAlex
Proteomic basis of modulation of postischemic fibrosis by MSC exosomes (2021)

7 citations DOI OpenAlex